Michael Fossel

Michael Fossel has an extensive background in medicine and academia. Michael has held various positions in different companies, focusing on areas such as physician consulting, teaching, and research. Currently, Michael is the President of Telocyte, a company working on developing telomerase therapy for Alzheimer's disease. In the past, Michael has also served as an Editor in Chief for OBM Geriatrics and held positions at Cerner Corporation and Trinity Health. Michael holds degrees in Medicine, Neurobiology, and Psychology from Stanford University and Wesleyan University.